Artgen Biotech PJSC (MIC:ABIO) EPS (Diluted) : ₽0.58 (TTM As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC EPS (Diluted)?

Artgen Biotech PJSC's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was ₽0.34. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was ₽0.58.

Artgen Biotech PJSC's EPS (Basic) for the six months ended in Jun. 2023 was ₽0.34. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was ₽0.58.

Artgen Biotech PJSC's EPS without NRI for the six months ended in Jun. 2023 was ₽0.26. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was ₽0.98.

During the past 12 months, Artgen Biotech PJSC's average EPS without NRIGrowth Rate was 140.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Artgen Biotech PJSC's highest 3-Year average EPS without NRI Growth Rate was 198.70% per year. The lowest was -31.60% per year. And the median was 0.70% per year.

Artgen Biotech PJSC EPS (Diluted) Historical Data

The historical data trend for Artgen Biotech PJSC's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC EPS (Diluted) Chart

Artgen Biotech PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Diluted)

Get a 7-Day Free Trial

-0.46

1.13

0.97

0.16

0.53

Artgen Biotech PJSC Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EPS (Diluted)	Get a 7-Day Free Trial															0.26	-0.10	0.29	0.24	0.34

Competitive Comparison of Artgen Biotech PJSC's EPS (Diluted)

For the Biotechnology subindustry, Artgen Biotech PJSC's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artgen Biotech PJSC's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's PE Ratio distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's PE Ratio falls into.

Artgen Biotech PJSC EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Artgen Biotech PJSC's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(46.118	-	0)	/	86.911
	=	0.53

Artgen Biotech PJSC's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(31.878	-	0)	/	92.645
	=	0.34

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₽0.58

Artgen Biotech PJSC (MIC:ABIO) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Artgen Biotech PJSC EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Artgen Biotech PJSC (MIC:ABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prospect of the 60th Anniversary, Moscow, RUS, 117036

Website

https://www.hsci.ru

Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.